Immunogenicity assay: Anti-drug antibody
Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.
To determine the cut point of a substance, or the level at which a substance is considered reactive for anti-drug antibodies (ADAs), you can receive a variety of screening and confirmatory tests in drug-naive populations. This component of immunogenicity assessments uses real-world trials and statistical approaches to determining the level at which ADAs activate in test populations.